Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil As the New Standard for Graft-Versus-Host Disease (GVHD) Prophylaxis in Reduced Intensity Conditioning: Results from Phase III BMT CTN 1703

Saved in:
Bibliographic Details
Published in:Blood 2022-12, Vol.140 (Supplement 2), p.LBA-4-LBA-4
Main Authors: Holtan, Shernan G, Hamadani, Mehdi, WU, Juan, AL Malki, Monzr M., Runaas, Lyndsey, Elmariah, Hany, Rezvani, Andrew R., Gooptu, Mahasweta, Larkin, Karilyn T., Shaffer, Brian C., El Jurdi, Najla H, Loren, Alison W., Solh, Melhem, Hall, Aric C., Alousi, Amin M, Jamy, Omer H, Perales, Miguel-Angel, Yao, Janny M., Applegate, Kristy, Bhatt, Ami S., Kean, Leslie S., Efebera, Yvonne A., Kitko, Carrie Lynn, Reshef, Ran, Clark, William, DiFronzo, Nancy L., Henderson, Lori, Jones, Richard J., Liefer, Eric, Martens, Michael J, Horowitz, Mary M., Bolanos-Meade, Javier
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2022-171463